Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Pepper

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Journal of Occupational and Environmental Medicine|October 9, 2019
Military Occupational Specialty Codes: Utility in Predicting Inhalation Exposures in Post-9/11 DeployersLauren M Zell-Baran, Richard Meehan, Jenna Wolff, et al.
Leukemia|July 4, 2014
The enzymatic activities of CD38 enhance CLL growth and trafficking: implications for therapeutic targetingT Vaisitti, V Audrito, S Serra, et al.
British Journal of Cancer|October 5, 2013
p53 and cell cycle independent dysregulation of autophagy in chronic lymphocytic leukaemiaM J Groves, C E Johnson, J James, et al.
Cell Proliferation|June 8, 2011
Two novel aspirin analogues show selective cytotoxicity in primary chronic lymphocytic leukaemia cells that is associated with dual inhibition of Rel A and COX-2C Pepper, J G Mahdi, A G S Buggins, et al.
Leukemia|March 12, 2026
High-risk molecular features may eclipse genomic complexity in predicting chronic lymphocytic leukemia outcomes; UK clinical trial insightsH Parker, L Carr, K Norris, et al.
Leukemia|August 11, 2015
Telomere length predicts progression and overall survival in chronic lymphocytic leukemia: data from the UK LRF CLL4 trialJ C Strefford, L Kadalayil, J Forster, et al.
Leukemia|January 22, 2010
Variant IRF4/MUM1 associates with CD38 status and treatment-free survival in chronic lymphocytic leukaemiaJ M Allan, N J Sunter, J R Bailey, et al.
Leukemia|November 4, 2014
Common variation at 12q24.13 (OAS3) influences chronic lymphocytic leukemia riskG P Sava, H E Speedy, M C Di Bernardo, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Journal of Occupational and Environmental Medicine|October 9, 2019
Military Occupational Specialty Codes: Utility in Predicting Inhalation Exposures in Post-9/11 DeployersLauren M Zell-Baran, Richard Meehan, Jenna Wolff, et al.
Leukemia|July 4, 2014
The enzymatic activities of CD38 enhance CLL growth and trafficking: implications for therapeutic targetingT Vaisitti, V Audrito, S Serra, et al.
British Journal of Cancer|October 5, 2013
p53 and cell cycle independent dysregulation of autophagy in chronic lymphocytic leukaemiaM J Groves, C E Johnson, J James, et al.
Cell Proliferation|June 8, 2011
Two novel aspirin analogues show selective cytotoxicity in primary chronic lymphocytic leukaemia cells that is associated with dual inhibition of Rel A and COX-2C Pepper, J G Mahdi, A G S Buggins, et al.
Leukemia|March 12, 2026
High-risk molecular features may eclipse genomic complexity in predicting chronic lymphocytic leukemia outcomes; UK clinical trial insightsH Parker, L Carr, K Norris, et al.
Leukemia|August 11, 2015
Telomere length predicts progression and overall survival in chronic lymphocytic leukemia: data from the UK LRF CLL4 trialJ C Strefford, L Kadalayil, J Forster, et al.
Leukemia|January 22, 2010
Variant IRF4/MUM1 associates with CD38 status and treatment-free survival in chronic lymphocytic leukaemiaJ M Allan, N J Sunter, J R Bailey, et al.
Leukemia|November 4, 2014
Common variation at 12q24.13 (OAS3) influences chronic lymphocytic leukemia riskG P Sava, H E Speedy, M C Di Bernardo, et al.
Pageof 7